Onc dx brst stg1-2 noprogres
Oncology; disease status; invasive female breast cancer (does not include ductal carcinoma in situ); adenocarcinoma as predominant cell type; stage i, or stage iia-iib; or t3, n1, m0; and er and pr negative; with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)
curl https://api.healthcare.dev/v1/codes/hcpcs/G9072 \ -H "Authorization: Bearer $HDEV_API_KEY"
{
"data": {
"code": "G9072",
"parent": null,
"status": "active",
"system": "hcpcs",
"display": "Onc dx brst stg1-2 noprogres",
"billable": true,
"attributes": {
"betos": "P7B",
"coverage": "C",
"action_code": "N",
"type_of_service": "1",
"pricing_indicator": "00",
"action_effective_date": "2007-01-01"
},
"description": "Oncology; disease status; invasive female breast cancer (does not include ductal carcinoma in situ); adenocarcinoma as predominant cell type; stage i, or stage iia-iib; or t3, n1, m0; and er and pr negative; with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)",
"replaced_by": [],
"effective_end": null,
"effective_start": "2006-01-01",
"care_categories": [],
"care_category_details": []
},
"meta": {
"source": "cms-hcpcs",
"data_version": "2026-10"
}
}CMS attributes
Change history
G9072 has been in effect since 2006-01-01. This page shows HCPCS Level II release 2026-10.
Add as_of=YYYY-MM-DD to the request to get this code exactly as it was on a past date. The change feed (GET /v1/changes) lists what each release added, changed or retired across the whole dataset; a per-code change list isn't published yet.
Use it
curl https://api.healthcare.dev/v1/codes/hcpcs/G9072 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up HCPCS Level II code G9072. Tell me what it covers, whether it is active and since when, and any CMS attributes it has.
Source: CMS, release 2026-10. Public domain (D-series CDT codes excluded). Reference data, not medical or billing advice.